febuxostat has been researched along with Liver Dysfunction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bayoumi, A; Fadl, RR; Gayyed, MF; Ibrahim, S; Ibrahim, YF; Refaie, M | 1 |
| Keenan, RT; Pillinger, MH | 1 |
| Grabowski, BA; Joseph-Ridge, N; Khosravan, R; Mayer, MD; Vernillet, L; Wu, JT | 1 |
1 review(s) available for febuxostat and Liver Dysfunction
| Article | Year |
|---|---|
Febuxostat: a new agent for lowering serum urate.
Topics: Animals; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Interactions; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Kidney Diseases; Liver Diseases; Thiazoles | 2009 |
1 trial(s) available for febuxostat and Liver Dysfunction
| Article | Year |
|---|---|
The effect of mild and moderate hepatic impairment on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase.
Topics: Administration, Oral; Adult; Biotransformation; Drug Administration Schedule; Enzyme Inhibitors; Febuxostat; Female; Humans; Liver Diseases; Male; Middle Aged; Thiazoles; Xanthine Oxidase | 2006 |
1 other study(ies) available for febuxostat and Liver Dysfunction
| Article | Year |
|---|---|
Protective effect of febuxostat in sepsis-induced liver and kidney injuries after cecal ligation and puncture with the impact of xanthine oxidase, interleukin 1
Topics: Acute Kidney Injury; Alanine Transaminase; Animals; Aspartate Aminotransferases; Cecum; Creatinine; Febuxostat; Interleukin-1beta; JNK Mitogen-Activated Protein Kinases; Kidney; Ligation; Liver; Liver Diseases; Male; Protective Agents; Rats, Wistar; Sepsis; Urea; Xanthine Oxidase | 2020 |